Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.44 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11665836 | 0.90 | ALOX15 (0.64) | ALOX15KMT2AMEN1CYP3A4 | |
| SCHEMBL11665834 | 0.90 | ALOX15 (0.64) | ALOX15KMT2AMEN1CYP3A4 | |
| SCHEMBL988359 | 0.86 | ALOX15 (0.59) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL8375220 | 0.85 | ALOX15 (0.50) | ALOX15HIF1AEPAS1TSHR | |
| SCHEMBL28480784 | 0.84 | ALOX15 (0.57) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL8160898 | 0.84 | ALOX15 (0.57) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL8374951 | 0.82 | ALOX15 (0.55) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL27995055 | 0.82 | ALOX15 (0.55) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL164899 | 0.81 | ALOX15 (0.53) | ALOX15HIF1AEPAS1TSHR | |
| SCHEMBL28452346 | 0.81 | ALOX15 (0.53) | ALOX15HIF1AEPAS1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| WO-2022122143-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| CN-107257844-B | Synergistic perfuming composition | 弗门尼舍有限公司 | 2021-09-14 | — | — | CN | claimed |
| US-10308895-B2 | Synergistic perfuming composition | FIRMENICH SA (CH) | 2019-06-04 | — | — | US | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-10240108-B2 | Particles for malodor reduction | THE PROCTER & GAMBLE COMPANY (US) | 2019-03-26 | — | — | US | claimed |
| US-8318222-B2 | Topical skin care formulation | MARY KAY, INC. (US) | 2012-11-27 | — | — | US | claimed |
| US-8039011-B2 | A temperature change composition including a neurosensory component, e.g., menthol, and a first phase change component having a first phase change temperature between 15-40 degrees C., e.g., hydrocarbon, wax; encapsulated evaporative cooling agent; refreshing; durability; receptivity with other skin item | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-10-18 | — | — | US | claimed |
| US-20110206793-A1 | TOPICAL SKIN CARE FORMULATION | MARY KAY INC. (US) | 2011-08-25 | — | — | US | claimed |
| EP-2207524-A2 | SKIN COOLING COMPOSITION | Kimberly-Clark Worldwide, Inc. (US) | 2010-07-21 | — | — | EP | claimed |
| EP-2059229-A2 | SKIN COOLING COMPOSITIONS | Kimberly-Clark Worldwide, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2009057000-A2 | SKIN COOLING COMPOSITION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20090110656-A1 | Skin cooling composition | KIMBERLY-CLARK WORLDWIDE, INC. | 2009-04-30 | — | — | US | claimed |
| WO-2008044154-A2 | SKIN COOLING COMPOSITIONS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-04-17 | — | — | WO | claimed |
| US-20080085290-A1 | Skin cooling compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-04-10 | — | — | US | claimed |
| US-20060040218-A1 | Terpene ether solvents | WYATT MARION F | 2006-02-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308895-B2 | Synergistic perfuming composition | PIR, TRPA1, CAPZB | ALOX15 242/4885HIF1A 984/4885EPAS1 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.